Elderberry: Cold and Flu Evidence, Syrups and Safety

What is elderberry?

Elderberry supplements usually contain preparations of the ripe fruit of Sambucus nigra, the European elder. Syrups, lozenges and gummies differ in fruit concentration and other ingredients. In Europe, people have long prepared both the berries and the flowers as foods and folk remedies. They are different plant parts: the respiratory trials below tested berry preparations, while the European Medicines Agency's elderflower assessment^[1] concerns specified flower preparations for early cold symptoms. Its conclusion rests on longstanding use and plausibility, with insufficient clinical trial evidence. A berry trial's dose does not establish a dose for elderflower tea.

From European household use to clinical testing

The European Medicines Agency's historical review^[2] traces elderberry syrups, juices and teas used for colds and other complaints in Britain and continental Europe. It records elderberry syrup in an eighteenth-century British pharmacopoeia and later uses in Germany and central Europe. The same report records laxative uses of berry syrup and tea, diuretic uses intended to increase urination, and juice preparations for nerve pain. These are historical practices described in handbooks, not modern treatment recommendations. The original books were not the clinical trials of today’s standardized extracts.

Why do people take elderberry?

What should you check on the label?

Look for the species, fruit rather than an unspecified plant part, actual serving size and extract amount. Check whether the amount is extract weight or equivalent starting fruit. Read added sugar and other active ingredients separately; a combination gummy's effects cannot be assigned to elderberry alone.

Choose a prepared food or clearly identified supplement rather than making remedies from unidentified wild berries, leaves or stems.

What are the drawbacks and safety concerns?

What does the cold and flu research show?

For colds, the most informative prevention trial enrolled 312 intercontinental air travelers. Its standardized extract^[3] did not significantly reduce the number who developed a cold (12 versus 17 episodes), but the elderberry group had fewer total sick days and lower symptom scores among reported episodes. That is suggestive for duration in this specific travel setting, not proof of everyday cold prevention. A review of five randomized trials^[4] likewise judged any shortening of colds uncertain. In the travel trial, a separate respiratory-symptom questionnaire did not show a significant difference. The favorable duration result applied to the 29 travelers who developed a defined cold, not to all 312 participants.

For influenza, a 2004 trial in 60 adults^[5] reported symptom relief about four days earlier with 15 mL elderberry syrup four times a day for five days than with placebo. An earlier 1995 report^[6] also described faster improvement with Sambucol during an influenza outbreak. Those older positive results are part of why syrup claims persist. The 2004 syrup dose was studied for influenza, not for colds or other elderberry products.

In Macknin's 2020 trial^[7], 87 patients aged five and older with confirmed influenza received elderberry or placebo. Time until symptoms became none or mild averaged 5.3 days with elderberry versus 4.9 with placebo; complete resolution averaged 8.6 versus 8.7 days. Neither difference supported faster recovery.

The 2004 and 2020 influenza trials differed in preparation and participants. Within the 2020 trial, more patients in the elderberry group than in the placebo group also took oseltamivir, an antiviral flu medicine; this complicates subgroup comparisons but does not erase the null overall result. A later exploratory split found slower symptom relief with elderberry among those who did not take oseltamivir. Because antiviral use was chosen rather than randomly assigned, that subgroup result does not establish that elderberry delayed recovery. The manufacturer supplied both study products and reviewed the manuscript before submission, alongside foundation and institutional support.

Amounts and duration in the studies

Adults and adolescents aged 13 and older in the trial took 15 mL of the study syrup four times daily for five days. Children aged 5–12 took it twice daily. Each 15 mL represented 5.7 g of elderberry fruit. The traveler trial used a different preparation: 600 mg/day extract capsules before travel, rising to 900 mg/day around the trip. There is no common dose that makes these syrups, capsules and gummies interchangeable.

What about combinations with echinacea?

A 2015 trial of Echinaforce Hotdrink^[8] compared a combination containing echinacea and elderberry with oseltamivir in 473 patients with early influenza symptoms. Its analysis reported that recovery with the combination met the study’s noninferiority criterion against the antiviral. That design asks whether the combination performs acceptably close to its comparator; it does not identify elderberry’s contribution.

Does elderberry improve cardiovascular risk markers?

In Curtis and colleagues’ twelve-week trial^[9], the reported analysis included 52 healthy postmenopausal women, 26 per group. They consumed placebo or an elderberry extract supplying 500 mg/day anthocyanins, the pigments found in the fruit. That figure describes anthocyanins, not simply 500 mg of an unspecified elderberry extract.

The study found no significant improvement in the measured cardiovascular risk markers, which included blood lipids, glucose, inflammatory markers and platelet reactivity—how readily these blood cells respond in clotting tests. Liver and kidney measurements remained within clinically acceptable ranges. That laboratory observation over twelve weeks does not establish long-term safety in other populations or a cardiovascular benefit.

What do newer glucose and gut studies show?

A 2024 crossover trial^[10] studied 355 g/day elderberry juice for one week against a flavored placebo beverage. Nineteen adults with overweight or obesity were randomized and 18 completed both periods, separated by a three-week break. Researchers supplied the background diet for the last four days of each period.

The glucose response to a test meal was lower after the elderberry period; the insulin difference was not statistically significant. However, the placebo meal contained about 15 g more sugar. This makes it difficult to separate a berry effect from the difference between the meals. The same study found more fat burned during the three-hour meal test, with no increase in total energy expenditure. That is a short-term metabolic measurement, not demonstrated weight loss.

Stool testing found differences in selected bacterial groups, but no clear overall separation of the microbial profiles. Such changes do not by themselves show relief of a digestive condition. The USDA funded the study; the authors declared no conflicts. The researchers themselves called for better-matched meals and longer studies.

An earlier pilot^[11] used 177 mL/day juice for one week with participants following their usual diets. Ten completed the study and nine were analyzed after one diabetes-related exclusion. Glucose and insulin responses did not improve. During the meal test, participants burned more carbohydrate and less fat—the opposite direction from the later trial. Exercise measurements did not show a clear advantage. The smaller dose, uncontrolled background diet and missing meal-test measurements make the studies difficult to compare. Neither establishes weight loss or a diabetes treatment benefit.

What does the cognition research show?

A six-month pilot^[12] tested American elderberry, Sambucus nigra subsp. canadensis, in 24 people with mild cognitive impairment. Participants took 5 mL of a specified juice three times daily or placebo; 20 completed follow-up. The study did not establish broad improvement in memory or overall cognitive function. A possible improvement in the speed of solving visual problems fell short of conventional statistical significance.

A 2025 reanalysis^[13] combined test results into cognitive scores and found a signal for cognitive flexibility—the ability to adapt or switch approaches. It used the same participants, so it is not an independent confirmation. The small sample and numerous tests leave substantial uncertainty. These findings concern a particular American elderberry juice, rather than the European elderberry syrups used in respiratory trials.

Bottom line

Elderberry has a long European food and medicinal history and a few human respiratory trials worth reading. The air-travel study suggests shorter colds among affected travelers without showing prevention; a small influenza trial was positive, while a later trial of confirmed flu found no faster recovery. The cardiovascular-marker trial was null. Metabolic findings conflict, and the positive glucose study had a sugar mismatch; gut and cognition findings remain preliminary. We cannot identify a reliably effective berry form or dose from those results. If you buy a syrup or gummy, check the actual fruit preparation and other ingredients, and judge its cost against an uncertain benefit.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly